Larger hypothalamic volume in narcolepsy type 1.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
08 Nov 2023
Historique:
received: 18 06 2022
revised: 18 05 2023
medline: 13 11 2023
pubmed: 18 7 2023
entrez: 18 7 2023
Statut: ppublish

Résumé

Narcolepsy type 1 (NT1) is a neurological sleep disorder. Postmortem studies have shown 75%-90% loss of the 50 000-70 000 hypocretin-producing neurons and 64%-94% increase in the 64 000-120 000 histaminergic neurons and conflicting indications of gliosis in the hypothalamus of NT1 patients. The aim of this study was to compare MRI-based volumes of the hypothalamus in patients with NT1 and controls in vivo. We used a segmentation tool based on deep learning included in Freesurfer and computed the volume of the whole hypothalamus, left/right part of the hypothalamus, and 10 hypothalamic subregions. We included 54 patients with post-H1N1 NT1 (39 females, mean age 21.8 ± 11.0 years) and 114 controls (77 females, mean age 23.2 ± 9.0 years). Group differences were tested with general linear models using permutation testing in Permutation Analysis of Linear Models and evaluated after 10 000 permutations, yielding two-tailed P-values. Furthermore, a stepwise Bonferroni correction was performed after dividing hypothalamus into smaller regions. The analysis revealed larger volume for patients compared to controls for the whole hypothalamus (Cohen's d = 0.71, p = 0.0028) and for the left (d = 0.70, p = 0.0037) and right part of the hypothalamus (d = 0.65, p = 0.0075) and left (d = 0.72, p = 0.0036) and right tubular-inferior (d = 0.71, p = 0.0037) hypothalamic subregions. In conclusion, patients with post-H1N1 NT1 showed significantly larger hypothalamic volume than controls, in particular in the tubular-inferior subregions which could reflect several processes as previous studies have indicated neuroinflammation, gliosis, and changes in the numbers of different cell types.

Identifiants

pubmed: 37463428
pii: 7226142
doi: 10.1093/sleep/zsad173
pmc: PMC10636249
pii:
doi:

Substances chimiques

Orexins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Norwegian Ministry of Health and Care Services
ID : 2019032
Organisme : Research Council of Norway
ID : 276082
Organisme : European Union's Horizon 2020 Research and Innovation
ID : 802998
Organisme : South-Eastern Norway Regional Health Authority
ID : 2019101

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Sleep Research Society.

Références

Nat Rev Neurol. 2015 Jul;11(7):401-13
pubmed: 26100750
Neurology. 2009 Aug 18;73(7):511-7
pubmed: 19687452
Sleep. 2020 Mar 12;43(3):
pubmed: 31606740
Brain Pathol. 2003 Jul;13(3):340-51
pubmed: 12946023
Arch Neurol. 2002 Oct;59(10):1553-62
pubmed: 12374492
J Neuroimmunol. 2020 Mar 4;342:577210
pubmed: 32179327
Neurology. 2013 Apr 2;80(14):1315-21
pubmed: 23486871
Neurology. 2002 Jun 25;58(12):1852-5
pubmed: 12084891
Sleep. 2012 Mar 01;35(3):345-51
pubmed: 22379240
Proc Natl Acad Sci U S A. 2023 May 9;120(19):e2220911120
pubmed: 37126681
Brain. 2013 Aug;136(Pt 8):2486-96
pubmed: 23884811
Lancet Neurol. 2013 Nov;12(11):1068-75
pubmed: 24107292
Semin Immunopathol. 2022 Sep;44(5):611-623
pubmed: 35445831
Lancet Neurol. 2017 Mar;16(3):200-207
pubmed: 28129985
PLoS One. 2012;7(3):e33723
pubmed: 22470463
Brain Pathol. 2022 Mar;32(2):e13027
pubmed: 34672414
J Neurol. 2015 Dec;262(12):2635-42
pubmed: 26338813
Neuro Endocrinol Lett. 2006 Dec;27(6):769-72
pubmed: 17187022
Nat Med. 2000 Sep;6(9):991-7
pubmed: 10973318
J Sleep Res. 2016 Apr;25(2):181-9
pubmed: 26610427
Ann Neurol. 2013 Dec;74(6):794-804
pubmed: 24006291
Neuron. 2000 Sep;27(3):469-74
pubmed: 11055430
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Nat Med. 2002 Nov;8(11):1186-8
pubmed: 12411926
Sleep Med. 2015 Jan;16(1):39-44
pubmed: 25554349
Sleep Med. 2016 Mar;19:17-22
pubmed: 27198942
Neuroimage. 2015 Dec;123:253-68
pubmed: 26074200
Eur Neuropsychopharmacol. 2014 Mar;24(3):397-409
pubmed: 24345721
Br J Pharmacol. 2021 Feb;178(4):750-769
pubmed: 32744724
Sleep Med. 2014 Feb;15(2):262-5
pubmed: 24468101
Sleep. 2018 Oct 1;41(10):
pubmed: 30016530
Neuroradiology. 2022 Jul;64(7):1351-1357
pubmed: 35013760
Sleep. 2003 Feb 1;26(1):44-6
pubmed: 12627731
Nat Rev Neurol. 2019 Sep;15(9):519-539
pubmed: 31324898
Sleep Med Rev. 2018 Apr;38:177-186
pubmed: 28847694
Neuroscience. 1991;44(2):465-81
pubmed: 1719449
Neurology. 2006 Sep 26;67(6):1023-7
pubmed: 17000972
Sleep. 1999 Feb 1;22(1):77-87
pubmed: 9989368
Sleep Med. 2005 Nov;6(6):531-6
pubmed: 15994127
Nat Rev Dis Primers. 2017 Feb 09;3:16100
pubmed: 28179647
Handb Clin Neurol. 2019;160:393-403
pubmed: 31277864
Neurosci Res. 2019 May;142:16-29
pubmed: 29580887
Am J Psychiatry. 2010 Apr;167(4):397-408
pubmed: 20123910
Neuroimage. 2018 Apr 1;169:407-418
pubmed: 29278774
Neuroimage. 2020 Dec;223:117287
pubmed: 32853816
Acta Neurol Scand. 2009 Jan;119(1):61-7
pubmed: 18624787
Sleep. 2009 Aug;32(8):993-8
pubmed: 19725250
Sleep Med. 2013 Sep;14(9):867-71
pubmed: 23773727
Sleep. 2007 Aug;30(8):969-73
pubmed: 17702265
Neuroimage. 2013 Apr 1;69:1-10
pubmed: 23247186
Ann Neurol. 2013 Dec;74(6):786-93
pubmed: 23821583
Sleep. 2010 Feb;33(2):169-76
pubmed: 20175400
Sleep. 2019 Jul 8;42(7):
pubmed: 30923809
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4471-6
pubmed: 21368172
Korean J Radiol. 2009 Nov-Dec;10(6):552-8
pubmed: 19885310

Auteurs

Hilde T Juvodden (HT)

Department of Rare Disorders, Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (NevSom), Oslo University Hospital, Ullevål, Oslo, Norway.

Dag Alnæs (D)

Division of Mental Health and Addiction, NORMENT Centre, University of Oslo and Oslo University Hospital, Oslo, Norway.
Departement of Psychology, Pedagogy and Law, Kristiania University College, Oslo, Norway.

Martina J Lund (MJ)

Division of Mental Health and Addiction, NORMENT Centre, University of Oslo and Oslo University Hospital, Oslo, Norway.
Norwegian Centre for Mental Disorders Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Ingrid Agartz (I)

Norwegian Centre for Mental Disorders Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
K.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.

OIe A Andreassen (OA)

Division of Mental Health and Addiction, NORMENT Centre, University of Oslo and Oslo University Hospital, Oslo, Norway.
K.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.

Andres Server (A)

Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Per M Thorsby (PM)

Hormone Laboratory, Department of Medical Biochemistry, Biochemical Endocrinology and Metabolism Research Group, Oslo University Hospital, Aker, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Lars T Westlye (LT)

Division of Mental Health and Addiction, NORMENT Centre, University of Oslo and Oslo University Hospital, Oslo, Norway.
K.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Stine Knudsen Heier (S)

Department of Rare Disorders, Norwegian Centre of Expertise for Neurodevelopmental Disorders and Hypersomnias (NevSom), Oslo University Hospital, Ullevål, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH